Response to Combination Therapy for Treatment or Prevention of Atherosclerosis
Shokei Kim‐Mitsuyama(Kumamoto University), Hisao Ogawa(Kumamoto University Hospital), Taishi Nakamura(Kumamoto University), Eiichiro Yamamoto(Sapporo Medical University)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753